About this trial
To provide a novel therapy idea and method to solve the clinical problem of postoperative adhesion of bilateral vocal cords, patients enrolled in this study will be applied with curcumin on both wound sites of bilateral vocal cords after the surgery on the bilateral vocal cord endoscopically.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with bilateral vocal cord diseases who are going to undergo resection of bilateral vocal cord lesions endoscopically.
Patients with bilateral vocal cord adhesion who are going to undergo incision of bilateral vocal cord adhesion endoscopically.
Disqualifiers
Patients with other laryngeal diseases.
Patients with cardiac and pulmonary insufficiency.
Patients unable to cooperate with the follow-up on time after surgery.
Patients who refuse to sign the informed consent after notification.
Trial design
Parallel
Treatments tested in this trial
Curcumin
DrugCurcumin was applied to both wound sites of bilateral vocal cords. After evenly applied, gently massage the applied site for 3-5 minutes until the drug was fully absorbed.
Mitomycin-C
DrugMitomycin-C was applied to both wound sites of bilateral vocal cords. After evenly applied, gently massage the applied site for 3-5 minutes until the drug was fully absorbed.
Treatment groups
Trial outcomes
Primary outcomes
Number of participants with laryngeal web formation as assessed by videolaryngoscope
All participants received the videolaryngoscope every month post-surgery, and a laryngeal web is defined as a visible adhesion whose length reached 1 mm or greater.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.